Results In-Line with Previously Announced Third Quarter Preliminary Results ~ ~ Third Quarter Revenue Increased 39% to $6.1 Million YoY and 11% ...

Through the extended contract, Vizient members will continue to have access to broader exposure and contracted pricing for the T2Dx ® Instrument, the T2Bacteria ® Panel and the T2Candida ® Panel, the ...

Elie Habib , CEO of Anghami and OSN+, said: "The success of this partnership is a testament to the power of collaboration and innovation. With this new investment from OSN Group, we are poised to ...

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing ...

Results for all three TransCon hGH starting dose cohorts, in first clinical trial of an indication outside of growth hormone deficiency, showed a safety and tolerability profile comparable to daily ...

Nirav Patel will join Mastech Digital on January 6, 2025. Vivek Gupta to Step Down as President and CEO and Director of the Board After 9 Years of Leadership. PITTSBURGH ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy, Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in idiopathic pulmonary ...

Inspira Technologies Oxy B.H.N. Ltd. , ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, announced the delivery of INSPIRAtm ART100 systems ...